美国德克萨斯大学安德森癌症中心癌症药物遗传学博士后职位

2014年09月04日

来源：知识人网整理

摘要：

Postdoctoral positions in the field of cancer pharmacogenomics are available immediately in Dr. Xifeng Wu's lab at The University of Texas MD Anderson Cancer Center. Fellows are being recruited for projects aimed at identifying biomarkers for the prediction of cancer treatment outcomes by integrating genetic variation information with clinical and epidemiological data utilizing our well-characterized patient populations and extensive collection of biospecimens. Dr. Wu's research group successfully executes contemporary epidemiologic strategies across the cancer continuum by employing advanced, state-of-the-art equipment including high- and mid-throughput assay platforms for genotyping, copy number analysis, next-generation sequencing, whole-genome expression profiling, as well as microRNA and metabolome profiling. Our capabilities include single-cell and high-content analysis, FISH, telomere length and mitochondrial DNA analysis, and other cell-based phenotypic studies.

上一篇：美国德克萨斯大学安德森癌症中心流行病科博士后职位

下一篇：美国普渡大学分子生物学、细胞生物学和信号转导博士后职位